Who is sponsoring NCT05752331?

NCT05752331 is sponsored by Bournemouth University.

What drugs are being tested in NCT05752331?

Interventions in NCT05752331: Physical activity behavioural modification.

What condition does NCT05752331 study?

NCT05752331 studies Long COVID.

Is NCT05752331 still recruiting?

NCT05752331 is currently completed. Last updated 4 August 2023.

Last reviewed 2023-08-04 · How we verify

NCT05752331

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Personalised Health Behaviour Coaching to Support Symptoms and Activities of Daily Living in Those With Long COVID-19.

Completed NA Last updated 4 August 2023

What this trial tests

NA trial testing Physical activity behavioural modification in Long COVID in 32 participants. Completed in 15 June 2023.

Timeline

1 November 2022

Primary endpoint
31 May 2023

15 June 2023

Quick facts

Lead sponsor	Bournemouth University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	32
Start date	1 November 2022
Primary completion	31 May 2023
Estimated completion	15 June 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Physical activity behavioural modification

Conditions studied

Long COVID — all drugs for Long COVID →

Sponsor

Bournemouth University

Who can join

18 and older, any sex, with Long COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot RCT aims to assess whether a simple PA behavioural modification intervention can be delivered safely and feasibly to individuals with Long COVID suffering long standing symptoms with concerns regarding their ability to perform activities of daily living. Participants will be randomised to receive an 8-week physical activity behavioural modification intervention alongside usual care or usual care alone. The primary outcome for this study is to assess the safety and feasibility of the intervention, including recruitment targets, randomisation, completion rates and acceptability to the study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Personalised Health Behaviour Support Programme in Adults With Post-COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial.
Armstrong M, Owen R, Van Niekerk KS, Saynor ZL. · · 2024 · cited 1× · PMID 39462879 · DOI 10.1111/hex.70079

Verify or expand the search:

Other recruiting trials for Long COVID

Currently open trials in the same condition.

NCT05931497 — Sauna for Long Covid · NA · recruiting
NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting

Other Bournemouth University trials

Trials by the same sponsor.

NCT07471243 — Dressing-related Experiences and Surgical Site Self-care in Hip and Knee Replacement: an Observational Cohort Study · not yet recruiting
NCT07096661 — Pain Science Education for Labour and Postpartum Pain · not yet recruiting
NCT07074275 — Chronic Fibromyalgia Pain, Lifestyle Factors, and Inflammation · active not recruiting
NCT06925932 — This Trial Aims to Assess the Effects of Three Different Taste-based Dietary Recommendations for Reducing Free Sugar Int · NA · enrolling by invitation
NCT06042907 — Development, Validation and Evaluation of the Feasibility of the Observational Risk Assessment of Contractures (Longitud · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05752331 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bournemouth University
Last refreshed: 4 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05752331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing